 | • レポートコード：MRC2-11QY04113 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は骨肉腫のグローバル市場について調査・分析したレポートです。種類別（生検、X線、磁気共鳴画像（MRI）スキャン、コンピューター断層撮影（CT）スキャン、骨スキャン）市場規模、用途別（病院・クリニック、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別骨肉腫の競争状況、市場シェア ・世界の骨肉腫市場：種類別市場規模 2015年-2020年（生検、X線、磁気共鳴画像（MRI）スキャン、コンピューター断層撮影（CT）スキャン、骨スキャン） ・世界の骨肉腫市場：種類別市場規模予測 2021年-2026年（生検、X線、磁気共鳴画像（MRI）スキャン、コンピューター断層撮影（CT）スキャン、骨スキャン） ・世界の骨肉腫市場：用途別市場規模 2015年-2020年（病院・クリニック、がん研究所） ・世界の骨肉腫市場：用途別市場規模予測 2021年-2026年（病院・クリニック、がん研究所） ・北米の骨肉腫市場分析：米国、カナダ ・ヨーロッパの骨肉腫市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの骨肉腫市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の骨肉腫市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの骨肉腫市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Spectrum Pharmaceuticals、Hikma Pharmaceuticals、Baxter、Isofol、Advaxis、Bellicum Pharmaceuticals、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
An osteosarcoma (OS) is a cancerous tumor in a bone. Specifically, it is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin (and thus a sarcoma) and that exhibits osteoblastic differentiation and produces malignant osteoid. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in teenagers and young adults.
Osteosarcoma is the eighth-most common form of childhood cancer, comprising 2.4% of all malignancies in pediatric patients, and about 20% of all primary bone cancers. Incidence rates for osteosarcoma in U.S. patients under 20 years of age are estimated at 5.0 per million per year in the general population, with a slight variation between individuals of black, Hispanic, and white ethnicities (6.8, 6.5, and 4.6 per million per year, respectively). It is slightly more common in males (5.4 per million per year) than in females (4.0 per million per year).
Market Analysis and Insights: Global Osteosarcoma Market
The global Osteosarcoma market size is projected to reach US$ 534.2 million by 2026, from US$ 514.9 million in 2020, at a CAGR of 3.5%% during 2021-2026.
Global Osteosarcoma Scope and Market Size
Osteosarcoma market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Osteosarcoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Spectrum Pharmaceuticals
Hikma Pharmaceuticals
Baxter
Isofol
Advaxis
Bellicum Pharmaceuticals
Novartis
Market segment by Type, the product can be split into
Biopsy
X-Ray
Magnetic Resonance Imaging (MRI) Scan
Computed Tomography (CT) Scan
Bone Scan
Market segment by Application, split into
Hospital & Clinics
Cancer Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Osteosarcoma Revenue
1.4 Market by Type
1.4.1 Global Osteosarcoma Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biopsy
1.4.3 X-Ray
1.4.4 Magnetic Resonance Imaging (MRI) Scan
1.4.5 Computed Tomography (CT) Scan
1.4.6 Bone Scan
1.5 Market by Application
1.5.1 Global Osteosarcoma Market Share by Application: 2020 VS 2026
1.5.2 Hospital & Clinics
1.5.3 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Osteosarcoma Market Perspective (2015-2026)
2.2 Global Osteosarcoma Growth Trends by Regions
2.2.1 Osteosarcoma Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Osteosarcoma Historic Market Share by Regions (2015-2020)
2.2.3 Osteosarcoma Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Osteosarcoma Market Growth Strategy
2.3.6 Primary Interviews with Key Osteosarcoma Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Osteosarcoma Players by Market Size
3.1.1 Global Top Osteosarcoma Players by Revenue (2015-2020)
3.1.2 Global Osteosarcoma Revenue Market Share by Players (2015-2020)
3.1.3 Global Osteosarcoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Osteosarcoma Market Concentration Ratio
3.2.1 Global Osteosarcoma Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Osteosarcoma Revenue in 2019
3.3 Osteosarcoma Key Players Head office and Area Served
3.4 Key Players Osteosarcoma Product Solution and Service
3.5 Date of Enter into Osteosarcoma Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Osteosarcoma Historic Market Size by Type (2015-2020)
4.2 Global Osteosarcoma Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Osteosarcoma Market Size by Application (2015-2020)
5.2 Global Osteosarcoma Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Osteosarcoma Market Size (2015-2020)
6.2 Osteosarcoma Key Players in North America (2019-2020)
6.3 North America Osteosarcoma Market Size by Type (2015-2020)
6.4 North America Osteosarcoma Market Size by Application (2015-2020)
7 Europe
7.1 Europe Osteosarcoma Market Size (2015-2020)
7.2 Osteosarcoma Key Players in Europe (2019-2020)
7.3 Europe Osteosarcoma Market Size by Type (2015-2020)
7.4 Europe Osteosarcoma Market Size by Application (2015-2020)
8 China
8.1 China Osteosarcoma Market Size (2015-2020)
8.2 Osteosarcoma Key Players in China (2019-2020)
8.3 China Osteosarcoma Market Size by Type (2015-2020)
8.4 China Osteosarcoma Market Size by Application (2015-2020)
9 Japan
9.1 Japan Osteosarcoma Market Size (2015-2020)
9.2 Osteosarcoma Key Players in Japan (2019-2020)
9.3 Japan Osteosarcoma Market Size by Type (2015-2020)
9.4 Japan Osteosarcoma Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Osteosarcoma Market Size (2015-2020)
10.2 Osteosarcoma Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Osteosarcoma Market Size by Type (2015-2020)
10.4 Southeast Asia Osteosarcoma Market Size by Application (2015-2020)
11 India
11.1 India Osteosarcoma Market Size (2015-2020)
11.2 Osteosarcoma Key Players in India (2019-2020)
11.3 India Osteosarcoma Market Size by Type (2015-2020)
11.4 India Osteosarcoma Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Osteosarcoma Market Size (2015-2020)
12.2 Osteosarcoma Key Players in Central & South America (2019-2020)
12.3 Central & South America Osteosarcoma Market Size by Type (2015-2020)
12.4 Central & South America Osteosarcoma Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Osteosarcoma Introduction
13.1.4 Pfizer Revenue in Osteosarcoma Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Spectrum Pharmaceuticals
13.2.1 Spectrum Pharmaceuticals Company Details
13.2.2 Spectrum Pharmaceuticals Business Overview
13.2.3 Spectrum Pharmaceuticals Osteosarcoma Introduction
13.2.4 Spectrum Pharmaceuticals Revenue in Osteosarcoma Business (2015-2020)
13.2.5 Spectrum Pharmaceuticals Recent Development
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Details
13.3.2 Hikma Pharmaceuticals Business Overview
13.3.3 Hikma Pharmaceuticals Osteosarcoma Introduction
13.3.4 Hikma Pharmaceuticals Revenue in Osteosarcoma Business (2015-2020)
13.3.5 Hikma Pharmaceuticals Recent Development
13.4 Baxter
13.4.1 Baxter Company Details
13.4.2 Baxter Business Overview
13.4.3 Baxter Osteosarcoma Introduction
13.4.4 Baxter Revenue in Osteosarcoma Business (2015-2020)
13.4.5 Baxter Recent Development
13.5 Isofol
13.5.1 Isofol Company Details
13.5.2 Isofol Business Overview
13.5.3 Isofol Osteosarcoma Introduction
13.5.4 Isofol Revenue in Osteosarcoma Business (2015-2020)
13.5.5 Isofol Recent Development
13.6 Advaxis
13.6.1 Advaxis Company Details
13.6.2 Advaxis Business Overview
13.6.3 Advaxis Osteosarcoma Introduction
13.6.4 Advaxis Revenue in Osteosarcoma Business (2015-2020)
13.6.5 Advaxis Recent Development
13.7 Bellicum Pharmaceuticals
13.7.1 Bellicum Pharmaceuticals Company Details
13.7.2 Bellicum Pharmaceuticals Business Overview
13.7.3 Bellicum Pharmaceuticals Osteosarcoma Introduction
13.7.4 Bellicum Pharmaceuticals Revenue in Osteosarcoma Business (2015-2020)
13.7.5 Bellicum Pharmaceuticals Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Osteosarcoma Introduction
13.8.4 Novartis Revenue in Osteosarcoma Business (2015-2020)
13.8.5 Novartis Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Osteosarcoma Key Market Segments
Table 2. Key Players Covered: Ranking by Osteosarcoma Revenue
Table 3. Ranking of Global Top Osteosarcoma Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Osteosarcoma Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biopsy
Table 6. Key Players of X-Ray
Table 7. Key Players of Magnetic Resonance Imaging (MRI) Scan
Table 8. Key Players of Computed Tomography (CT) Scan
Table 9. Key Players of Bone Scan
Table 10. Global Osteosarcoma Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Osteosarcoma Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Osteosarcoma Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Osteosarcoma Market Share by Regions (2015-2020)
Table 14. Global Osteosarcoma Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Osteosarcoma Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Osteosarcoma Market Growth Strategy
Table 20. Main Points Interviewed from Key Osteosarcoma Players
Table 21. Global Osteosarcoma Revenue by Players (2015-2020) (Million US$)
Table 22. Global Osteosarcoma Market Share by Players (2015-2020)
Table 23. Global Top Osteosarcoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteosarcoma as of 2019)
Table 24. Global Osteosarcoma by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Osteosarcoma Product Solution and Service
Table 27. Date of Enter into Osteosarcoma Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Osteosarcoma Market Size by Type (2015-2020) (Million US$)
Table 30. Global Osteosarcoma Market Size Share by Type (2015-2020)
Table 31. Global Osteosarcoma Revenue Market Share by Type (2021-2026)
Table 32. Global Osteosarcoma Market Size Share by Application (2015-2020)
Table 33. Global Osteosarcoma Market Size by Application (2015-2020) (Million US$)
Table 34. Global Osteosarcoma Market Size Share by Application (2021-2026)
Table 35. North America Key Players Osteosarcoma Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Osteosarcoma Market Share (2019-2020)
Table 37. North America Osteosarcoma Market Size by Type (2015-2020) (Million US$)
Table 38. North America Osteosarcoma Market Share by Type (2015-2020)
Table 39. North America Osteosarcoma Market Size by Application (2015-2020) (Million US$)
Table 40. North America Osteosarcoma Market Share by Application (2015-2020)
Table 41. Europe Key Players Osteosarcoma Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Osteosarcoma Market Share (2019-2020)
Table 43. Europe Osteosarcoma Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Osteosarcoma Market Share by Type (2015-2020)
Table 45. Europe Osteosarcoma Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Osteosarcoma Market Share by Application (2015-2020)
Table 47. China Key Players Osteosarcoma Revenue (2019-2020) (Million US$)
Table 48. China Key Players Osteosarcoma Market Share (2019-2020)
Table 49. China Osteosarcoma Market Size by Type (2015-2020) (Million US$)
Table 50. China Osteosarcoma Market Share by Type (2015-2020)
Table 51. China Osteosarcoma Market Size by Application (2015-2020) (Million US$)
Table 52. China Osteosarcoma Market Share by Application (2015-2020)
Table 53. Japan Key Players Osteosarcoma Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Osteosarcoma Market Share (2019-2020)
Table 55. Japan Osteosarcoma Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Osteosarcoma Market Share by Type (2015-2020)
Table 57. Japan Osteosarcoma Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Osteosarcoma Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Osteosarcoma Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Osteosarcoma Market Share (2019-2020)
Table 61. Southeast Asia Osteosarcoma Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Osteosarcoma Market Share by Type (2015-2020)
Table 63. Southeast Asia Osteosarcoma Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Osteosarcoma Market Share by Application (2015-2020)
Table 65. India Key Players Osteosarcoma Revenue (2019-2020) (Million US$)
Table 66. India Key Players Osteosarcoma Market Share (2019-2020)
Table 67. India Osteosarcoma Market Size by Type (2015-2020) (Million US$)
Table 68. India Osteosarcoma Market Share by Type (2015-2020)
Table 69. India Osteosarcoma Market Size by Application (2015-2020) (Million US$)
Table 70. India Osteosarcoma Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Osteosarcoma Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Osteosarcoma Market Share (2019-2020)
Table 73. Central & South America Osteosarcoma Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Osteosarcoma Market Share by Type (2015-2020)
Table 75. Central & South America Osteosarcoma Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Osteosarcoma Market Share by Application (2015-2020)
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Osteosarcoma Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. Spectrum Pharmaceuticals Company Details
Table 83. Spectrum Pharmaceuticals Business Overview
Table 84. Spectrum Pharmaceuticals Product
Table 85. Spectrum Pharmaceuticals Revenue in Osteosarcoma Business (2015-2020) (Million US$)
Table 86. Spectrum Pharmaceuticals Recent Development
Table 87. Hikma Pharmaceuticals Company Details
Table 88. Hikma Pharmaceuticals Business Overview
Table 89. Hikma Pharmaceuticals Product
Table 90. Hikma Pharmaceuticals Revenue in Osteosarcoma Business (2015-2020) (Million US$)
Table 91. Hikma Pharmaceuticals Recent Development
Table 92. Baxter Company Details
Table 93. Baxter Business Overview
Table 94. Baxter Product
Table 95. Baxter Revenue in Osteosarcoma Business (2015-2020) (Million US$)
Table 96. Baxter Recent Development
Table 97. Isofol Company Details
Table 98. Isofol Business Overview
Table 99. Isofol Product
Table 100. Isofol Revenue in Osteosarcoma Business (2015-2020) (Million US$)
Table 101. Isofol Recent Development
Table 102. Advaxis Company Details
Table 103. Advaxis Business Overview
Table 104. Advaxis Product
Table 105. Advaxis Revenue in Osteosarcoma Business (2015-2020) (Million US$)
Table 106. Advaxis Recent Development
Table 107. Bellicum Pharmaceuticals Company Details
Table 108. Bellicum Pharmaceuticals Business Overview
Table 109. Bellicum Pharmaceuticals Product
Table 110. Bellicum Pharmaceuticals Revenue in Osteosarcoma Business (2015-2020) (Million US$)
Table 111. Bellicum Pharmaceuticals Recent Development
Table 112. Novartis Business Overview
Table 113. Novartis Product
Table 114. Novartis Company Details
Table 115. Novartis Revenue in Osteosarcoma Business (2015-2020) (Million US$)
Table 116. Novartis Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Osteosarcoma Market Share by Type: 2020 VS 2026
Figure 2. Biopsy Features
Figure 3. X-Ray Features
Figure 4. Magnetic Resonance Imaging (MRI) Scan Features
Figure 5. Computed Tomography (CT) Scan Features
Figure 6. Bone Scan Features
Figure 7. Global Osteosarcoma Market Share by Application: 2020 VS 2026
Figure 8. Hospital & Clinics Case Studies
Figure 9. Cancer Research Institutes Case Studies
Figure 10. Osteosarcoma Report Years Considered
Figure 11. Global Osteosarcoma Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Osteosarcoma Market Share by Regions: 2020 VS 2026
Figure 13. Global Osteosarcoma Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Osteosarcoma Market Share by Players in 2019
Figure 16. Global Top Osteosarcoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteosarcoma as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Osteosarcoma Revenue in 2019
Figure 18. North America Osteosarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Osteosarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Osteosarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Osteosarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Osteosarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Osteosarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Osteosarcoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
モバイル画像の世界市場（～2026年） Mobile imaging technology is primarily used in the diagnosis of diseases by providing detailed images of the body. The mobile imaging market is growing due to innovative applications of the technology in various areas such as cardiology, neurology, and women’s health. The growing importance of medic…- 脳卒中管理の世界市場（～2026年） Stroke is the condition that occurs when the clot is formed in the artery and the oxygen supply to the brain is cut off, brain cells get deprived of oxygen and starts to die. Stroke can be thrombotic or embolic. Thrombotic stroke occurs when a blood clot is formed in the arteries that supply blood t…
- 磁気共鳴画像の世界市場（～2026年） Market Analysis and Insights: Global Magnetic Resonance Imaging Market The global Magnetic Resonance Imaging market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Magnetic Resonance Imaging Scope and Market Size Magnetic Res…
- 磁気共鳴造影剤の世界市場（～2026年） Market Analysis and Insights: Global Magnetic Resonance Contrast Agents Market The global Magnetic Resonance Contrast Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Magnetic Resonance Contrast Agents Scope and …
- 磁気共鳴画像法（MRI）用造影剤の世界市場（～2026年） Market Analysis and Insights: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market The global Contrast Agents for Magnetic Resonance Imaging (MRI) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Contrast …